Patent Assignment
Reel/Frame 054344/0218
Security Interest
Recorded: 2020-11-06
Pages: 13
Assignors
IMMUNOCORE LIMITED
Executed: 2020-11-06
IMMUNOCORE LLC
Executed: 2020-11-06
IMMUNOCORE COMMERCIAL LLC
Executed: 2020-11-06
Assignee
OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
2 ROUTE D'ARLON, STRASSEN, 8008, LUXEMBOURG
Covered Properties
(59)
Soluble T Cell Receptor
Single Chain Recombinant T Cell Receptors
Modified Soluble T Cell Receptor
Cells Expressing a Modified T Cell Receptor
Soluble T Cell Receptors
T Cell Receptor Display
Bifunctional Polypeptides
Non-naturally occurring T cell receptors
Cells Expressing Modified T Cell Receptor
Nucleic Acid Molecules Encoding Non-Naturally Occurring T Cell Receptors and Cells Thereof
T Cell Receptor Display
T Cell Receptor Display
Method for Predicting the Off-Target Biding of a Peptide Which Binds to a Target Peptide Presented by a Major Histocompatibility Complex
Tcr Libraries
Application:
15/262,160 →
Publication:
US 2017/0051036
Tcr Libraries
Tcr Libraries
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Peptides
Application:
15/777,149 →
Publication:
US 2018/0327466
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides Derived from Achaete-Scute Homolog 2 (ASCL2), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,163 →
Publication:
US 2018/0355006
Peptides Derived from Prostate Specific Antigen (KLK3) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,613 →
Publication:
US 2018/0339028
Peptides Derived from Lengsin (Lgsn), Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides Derived from Homeobox Protein B13 (Hox-B13) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,875 →
Publication:
US 2018/0339029
Peptides
Application:
15/777,877 →
Publication:
US 2018/0346545
Peptides from NPSR1
Application:
15/777,880 →
Publication:
US 2018/0339027
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
15/777,883 →
Publication:
US 2018/0346511
Peptides Derived from Prorelaxin H1 (RLN1)
Application:
15/778,177 →
Publication:
US 2018/0340016
Peptides Derived from Sarcoma Antigen 1 (SAGE1) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/778,179 →
Publication:
US 2018/0346536
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
15/778,199 →
Publication:
US 2018/0346517
Peptides
Application:
15/778,204 →
Publication:
US 2018/0340018
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
T Cell Receptors Specific for the Ny-Eso-1 Tumor Antigen-Hla-a*02 Complex
Peptides
Application:
16/084,883 →
Publication:
US 2019/0083591
Engineered Immune-Mobilizing T-Cell Receptors with Enhanced Affinity for Hiv-1 Gag
T Cell Receptors
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
16/097,582 →
Publication:
US 2019/0153053
Bifunctional Polypeptides
Application:
16/151,144 →
Publication:
US 2019/0247512
Dosing Regimen for GP100-Specific Tcr - Anti-CD3 Scfv Fusion Protein
Peptides
Application:
16/347,384 →
Publication:
US 2021/0115099
Bifunctional Polypeptides
Bifunctional Polypeptides
Bifunctional Polypeptides
T Cell Receptors
Peptides
Application:
16/938,263 →
Publication:
US 2021/0054080
A Method of Detecting MAGEA4
Application:
16/979,146 →
Publication:
US 2020/0400674
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
16/985,058 →
Publication:
US 2021/0017250
Peptides
Application:
16/985,061 →
Publication:
US 2021/0017227
Peptides
Application:
16/988,425 →
Publication:
US 2021/0032301
Peptides
Application:
16/988,431 →
Publication:
US 2021/0017228
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
16/988,523 →
Publication:
US 2021/0093732
Peptides from PIWIL1
Application:
16/994,399 →
Publication:
US 2021/0061857
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Application:
16/997,731 →
Publication:
US 2021/0145936
Peptides Derived from Kallikrein 4
Application:
16/998,945 →
Publication:
US 2021/0047629
Peptides
Application:
17/010,653 →
Publication:
US 2021/0054045
Peptides
Application:
17/013,228 →
Publication:
US 2021/0054036
Claudin-6 Peptides
Application:
17/017,444 →
Publication:
US 2021/0061874
Peptides of PAGE5
Application:
17/017,457 →
Publication:
US 2021/0054037
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
17/031,691 →
Publication:
US 2021/0101949
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/065,509 →
Publication:
US 2021/0121526
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 1, 2004
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 015800/0973 →
Assignment of Assignor's Interest
Aug 29, 2005
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 016921/0249 →
Assignment of Assignor's Interest
Apr 5, 2006
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 017958/0155 →
Change of Name
Nov 12, 2007
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 020097/0212 →
Change of Name
May 19, 2008
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 020965/0880 →
Change of Name
Aug 12, 2008
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 021370/0378 →
Assignment of Assignor's Interest
Jan 8, 2009
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 022076/0044 →
Assignment of Assignor's Interest
Apr 13, 2009
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 022538/0727 →
Change of Name
Feb 20, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027731/0117 →
Assignment of Assignor's Interest
Feb 20, 2012
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 027731/0073 →
Assignment of Assignor's Interest
Mar 23, 2012
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 027915/0868 →
Change of Name
Mar 23, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027915/0667 →
Assignment of Assignor's Interest
Mar 23, 2012
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 027915/0576 →
Assignment of Assignor's Interest
Apr 5, 2012
From: JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE; LI, YI
To: IMMUNOCORE LIMITED
Reel/Frame 027995/0465 →
Assignment of Assignor's Interest
Dec 17, 2012
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 029482/0432 →
Assignment of Assignor's Interest
Feb 7, 2013
From: JAKOBSEN, BENT KARSTEN; HARWOOD, NAOMI; LIDDY, NATHANIEL ROSS
To: IMMUNOCORE LIMITED
Reel/Frame 029769/0388 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0150 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0190 →
Assignment of Assignor's Interest
Apr 10, 2014
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 032643/0399 →
Change of Name
Apr 10, 2014
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 032643/0481 →
Assignment of Assignor's Interest
Apr 11, 2014
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 032658/0612 →
Change of Name
Apr 11, 2014
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 032658/0776 →
Assignment of Assignor's Interest
Apr 14, 2014
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED
Reel/Frame 032662/0815 →
Assignment of Assignor's Interest
Apr 14, 2014
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 032662/0754 →
Corrective Assignment to Correct the Assignees Previously Recorded at Reel: 032662 Frame: 0815. Assignor(S) Hereby Confirms the Assignment.
Jun 10, 2014
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 033109/0597 →